This weblog is going for a short sabbatical over the holidays. Here's hoping to more innovations in life science research, more venture capital pouring into biotech, and more biotech products...
Read the full post.
Filed in archive Stem Cells
by ruth on December 23, 2005
Using stem cells derived from their bone marrow, children suffering from traumatic brain injury will be treated in a first clinical trial of its kind. The clinical trial is FDA-approved and builds on...
Read the full post.
FDA grants orphan drug designation to Adherex Technologies' lead candidate, Eniluracil, which has been designed to improve the effectiveness of fluoropyrimidines or 5-FU in liver cancer...
Read the full post.
The newly-established Toscana Life Sciences Park is calling for applications from individuals, individuals, companies and organizations who would like to set up shop in Siena, Italy. The science park...
Read the full post.
Yesterday, Acologix Inc., a privately held biopharmaceutical company, announced that it has raised $25.3 million in Series C financing, bringing its total raised fund to over $72 million. Most of the...
Read the full post.
Anthrax is an acute infectious disease caused by toxins produced by Bacillus anthracis. While cutaneous anthrax are rarely fatal, anthrax contracted via inhalation or ingestion has a case fatality...
Read the full post.
I am going to deviate for a moment from serious stuff and feature an ingenious (hypothetical?) board game published on the The Science Creative Quarterly. The Biotech Game of Life is a parody of...
Read the full post.
Acambis reached where no other company has yet: Phase II clinical trial for ChimeriVaxÖWest Nile, its investigational vaccine against the West Nile Virus. While most infections with the West Nile...
Read the full post.
In a multimillion euro deal, BASF Plant Science gains exclusive license rights to genetic traits discovered and validated by CropDesign for commercial use in major crops, such as corn, soybean and...
Read the full post.
Following its announcement of intending a full takeover of Chiron Vaccines, Swiss pharma giant Novartis considers acquiring another Swiss biotech company, Berna Biotech AG, to complement its product...
Read the full post.
A number of diseases are associated with protein aggregation and the formation and accumulation of amyloid fibers, including Parkinson's, Alzheimer's and Creuzfeldt-Jacob disease, as well as...
Read the full post.
Resulting from their efforts to find methods to reduce atmospheric levels of carbon dioxide, motorbike manufacturer Yamaha Motor, stumbles upon a potential anti-acne and anti-ageing lead compound from...
Read the full post.
Although anecdotal reports suggest that cannabis may be used to alleviate symptoms of depression, the psychotropic effects and abuse liability of this drug prevent its therapeutic application. The...
Read the full post.
Based on a technique first used in Arabidopsis, scientists from the Texas A&M University's Vegetable and Fruit Improvement Center and Baylor's College of Medicine were able to engineer a...
Read the full post.
An article in the December issue of the Journal of Cosmetic Dermatology reviews the current treatment applications and limitations of Botox (BTX-A), aside from that which is most popular, which is...
Read the full post.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) handed over a three-year grant of approximately $740,000 to Ceregene, Inc., to help fund Ceregene's Phase I clinical study of...
Read the full post.
Amgen and Abgenix have been collaborating on developing two major cancer drug candidates, one of which, panitumumab, has been shown effective against colorectal cancer therapy in its Phase 3 clinical...
Read the full post.
The National Cancer Institute and the National Human Genome Research Institute will pool together some $100 million to fund a 3-year pilot phase of The Cancer Genome Atlas project, which aims to...
Read the full post.
Kellogg, one of the biggest cereal and convenience food manufacturer, will reformulate some of its products to make use of soybean oil from Monsanto's Vistive(R) soybeans, in an effort to reduce...
Read the full post.
This week, some entries from the Biotech Weblog have been featured in a couple of blog carnivals focusing on health and medicine. A blog carnival is a compendium of blog entries all related to a...
Read the full post.
